Literature DB >> 17163395

Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness.

Arnold S Monto1, Lorraine Comanor, David K Shay, William W Thompson.   

Abstract

Along with continual enhancement of current influenza surveillance programs, pandemic preparedness also involves application of current surveillance techniques to past pandemics to identify their viruses and patterns, as well as estimation of the potential burden of future pandemics. Although mortality surveillance has been in place in selected locations for more than a century, the recent development of molecular diagnostics has shed new light on the origin and structure of the viruses responsible for the past 3 pandemics, allowing for comparisons with new viruses identified through ongoing viral surveillance. Models previously used to estimate hospitalizations and mortality associated with past epidemics and pandemics have evolved to estimate the burden and required surge capacity of future pandemics of different severities.

Mesh:

Year:  2006        PMID: 17163395     DOI: 10.1086/507559

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Enhancement of influenza surveillance with aggregate rapid influenza test results: New Mexico, 2003-2007.

Authors:  Joan Baumbach; Mark Mueller; Chad Smelser; Bernadette Albanese; C Mack Sewell
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

Review 2.  Health systems' "surge capacity": state of the art and priorities for future research.

Authors:  Samantha K Watson; James W Rudge; Richard Coker
Journal:  Milbank Q       Date:  2013-03       Impact factor: 4.911

Review 3.  Communicating risk and promoting disease mitigation measures in epidemics and emerging disease settings.

Authors:  Renata Schiavo; May May Leung; Mason Brown
Journal:  Pathog Glob Health       Date:  2014-03       Impact factor: 2.894

Review 4.  Connecting the study of wild influenza with the potential for pandemic disease.

Authors:  Jonathan Runstadler; Nichola Hill; Islam T M Hussein; Wendy Puryear; Mandy Keogh
Journal:  Infect Genet Evol       Date:  2013-03-26       Impact factor: 3.342

5.  Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.

Authors:  V Baldo; T Baldovin; A Floreani; E Fragapane; R Trivello
Journal:  J Clin Immunol       Date:  2007-05-21       Impact factor: 8.317

6.  Rapid detection of pandemic influenza in the presence of seasonal influenza.

Authors:  Brajendra K Singh; Nicholas J Savill; Neil M Ferguson; Chris Robertson; Mark Ej Woolhouse
Journal:  BMC Public Health       Date:  2010-11-24       Impact factor: 3.295

7.  Influenza surveillance among outpatients and inpatients in Morocco, 1996-2009.

Authors:  Amal Barakat; Hassan Ihazmad; Samira Benkaroum; Imad Cherkaoui; Abderahman Benmamoun; Mohammed Youbi; Rajae El Aouad
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

8.  Validation of a Pediatric Primary Care Network in a US Metropolitan Region as a Community-Based Infectious Disease Surveillance System.

Authors:  Kristen A Feemster; Yimei Li; Robert Grundmeier; A Russell Localio; Joshua P Metlay
Journal:  Interdiscip Perspect Infect Dis       Date:  2011-12-07

9.  Review of an influenza surveillance system, Beijing, People's Republic of China.

Authors:  Peng Yang; Wei Duan; Min Lv; Weixian Shi; Xiaoming Peng; Xiaomei Wang; Yanning Lu; Huijie Liang; Holly Seale; Xinghuo Pang; Quanyi Wang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

10.  Burden of Influenza in 4 Ecologically Distinct Regions of Peru: Household Active Surveillance of a Community Cohort, 2009-2015.

Authors:  Yeny O Tinoco; Eduardo Azziz-Baumgartner; Timothy M Uyeki; Hugo R Rázuri; Matthew R Kasper; Candice Romero; Maria E Silva; Mark P Simons; Giselle M Soto; Marc-Alain Widdowson; Robert H Gilman; Daniel G Bausch; Joel M Montgomery
Journal:  Clin Infect Dis       Date:  2017-10-16       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.